Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance.

Míreanna comhchosúla

• Epigenetic changes in urothelial cancer: A feature of the invasive phenotype and a novel therapeutic target
  de réir: Catto, J, et al.
  Foilsithe / Cruthaithe: (2006)
• DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
  de réir: Catto, J, et al.
  Foilsithe / Cruthaithe: (2006)
• [Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract].
  de réir: Burger, M, et al.
  Foilsithe / Cruthaithe: (2006)
• Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract
  de réir: Burger, M, et al.
  Foilsithe / Cruthaithe: (2006)
• Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
  de réir: Dhawan, D, et al.
  Foilsithe / Cruthaithe: (2006)